WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 17 fonti

'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows | CBC News

An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.

Raccontata dapbs.orgfranceinfo.frhealio.combiopharmadive.commedpagetoday.comnbcnews.comindependent.co.uktheguardian.comdailymail.commirror.co.ukcbsnews.comfortune.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
cbc.caStai leggendo16 h fa

'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows | CBC News

Revolution Medicines' daraxonrasib doubled pancreatic cancer survival (13 vs 7 months) in Phase 3 trial, halting tumor progression in 29% versus chemotherapy's 10%. First KRAS inhibitor success after 60 years; signals precision-medicine viability and reshapes oncology drug-development strategy for lethal mutations.

originale
newsbytesapp.com1 g fa

This drug can double survival time for pancreatic cancer patients

Daraxonrasib, a daily oral KRAS inhibitor, doubled median survival in advanced pancreatic cancer patients to 13.2 months versus 6.6 months for chemotherapy, in a 500-patient Phase III trial presented at ASCO 2026. With KRAS mutations driving 90%+ of pancreatic ductal adenocarcinomas, this validates targeted KRAS inhibition as a viable clinical pathway and signals a pipeline shift toward oncology precision medicine investments.

Leggi questa versione → originale
theguardian.com1 g fa

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

Leggi questa versione → originale
cbsnews.com1 g fa

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Leggi questa versione → originale
newscientist.com18 h fa

'Transformative' pancreatic cancer drug doubles survival time

Daraxonrasib doubled survival to 13.2 months (vs 6.7) in 500 treatment-resistant pancreatic cancer patients, with 90% lower side-effect dropout rates. First KRAS breakthrough in two decades; signals precision medicine momentum for oncology data stack and biotech investment decisions.

Leggi questa versione → originale
eu.usatoday.com21 h fa

Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who can get it.

Leggi questa versione → originale

Timeline cronologica

  1. sabato 30 maggio 2026·pbs.org

    Pancreatic cancer is deadly and difficult to treat. A new pill could change that

    The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

  2. sabato 30 maggio 2026·franceinfo.fr

    "C'est une révolution" : pourquoi le daraxonrasib, un nouveau traitement contre le cancer du pancréas, suscite de grands espoirs

    Cet anticancéreux multiplie par deux l'espérance de vie des patients atteints du cancer du pancréas, l'un des plus mortels et contre lequel peu de solutions existent. Les…

  3. domenica 31 maggio 2026·healio.com

    Daraxonrasib offers ‘transformational’ benefit in metastatic pancreatic cancer

    CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the buzz it created among ASCO Annual Meeting…

  4. domenica 31 maggio 2026·biopharmadive.com

    ‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer

    Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.

  5. domenica 31 maggio 2026·medpagetoday.com

    'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

    RASolute 302 findings herald a new standard of care in previously treated patients

  6. domenica 31 maggio 2026·nbcnews.com

    After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

    The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

  7. domenica 31 maggio 2026·independent.co.uk

    Daily pill almost doubles survival time for pancreatic cancer patients in new trial

    Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

  8. domenica 31 maggio 2026·theguardian.com

    Daily pill can double survival time for world’s deadliest cancer, trial shows

    Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

  9. domenica 31 maggio 2026·dailymail.com

    New drug gives extra months of life to pancreatic cancer patients

    Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.

  10. domenica 31 maggio 2026·independent.co.uk

    Experimental pill promises new hope for deadly pancreatic cancer

    New research shows a novel pill is helping people with advanced pancreatic cancer live longer

  11. domenica 31 maggio 2026·mirror.co.uk

    Cancer breakthrough as new 'game-changing' pill could double survival time

    Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that

  12. domenica 31 maggio 2026·independent.co.uk

    Pancreatic cancer breakthrough as pill almost doubles survival time for patients

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  13. domenica 31 maggio 2026·cbsnews.com

    New drug nearly doubles survival rates in some pancreatic cancer patients, study says

    New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

  14. domenica 31 maggio 2026·fortune.com

    Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

    The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…

  15. domenica 31 maggio 2026·cnn.com

    Experimental pill promises new hope for deadly pancreatic cancer | CNN

    A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

  16. domenica 31 maggio 2026·dailysabah.com

    Experimental pill offers breakthrough hope in pancreatic cancer fight

    An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...

  17. domenica 31 maggio 2026·inews.co.uk

    Why this new pill for a deadly cancer has doctors excited

    The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer

  18. domenica 31 maggio 2026·pbs.org

    Experimental drug shows promise against deadly pancreatic cancer

    A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

  19. lunedì 1 giugno 2026·nature.com

    Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

    Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.

  20. lunedì 1 giugno 2026·sciencealert.com

    Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

    WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…